Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Cash & Equivalents (2020 - 2025)

Bio Essence has reported Cash & Equivalents over the past 6 years, most recently at $28741.0 for Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 3.61% year-over-year to $28741.0; the TTM value through Sep 2025 reached $28741.0, down 3.61%, while the annual FY2024 figure was $1371.0, 1102.63% up from the prior year.
  • Cash & Equivalents for Q3 2025 was $28741.0 at Bio Essence, up from $1371.0 in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $29818.0 in Q3 2024 and troughed at $89.0 in Q3 2023.
  • A 5-year average of $7240.0 and a median of $572.0 in 2022 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: crashed 98.53% in 2022 and later soared 33403.37% in 2024.
  • Year by year, Cash & Equivalents stood at $303.0 in 2021, then soared by 1966.67% to $6262.0 in 2022, then plummeted by 98.18% to $114.0 in 2023, then surged by 1102.63% to $1371.0 in 2024, then surged by 1996.35% to $28741.0 in 2025.
  • Business Quant data shows Cash & Equivalents for BIOE at $28741.0 in Q3 2025, $1371.0 in Q4 2024, and $29818.0 in Q3 2024.